Nutra Pharma Corporation: Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications
Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation
Plantation, Florida--(Newsfile Corp. - February 23, 2021) - Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, is providing updates today on their work in improving their existing facilities for manufacturing and validation of their drug products, including their technologies as potential countermeasures against nerve agents like sarin gas and VX.